Ammonia
In clinical developmentAlso known as NH3 - Ammonia, Snap Labs.
Recent clinical, regulatory, research and industry developments relating to this drug.
Ammonia at the net-zero crossroads
Ammonia pressure controls colloidal metal nitride synthesis in molten salts
An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients
Efficacy of Topical Agents in the Treatment of Chrysaora Chinensis Stings
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- Nature communications1
- Nature nanotechnology1
- Akdim O1
- Chen FY1
- Cullen DA1
- Fang JY1
- Finfrock YZ1
- Gao G1
- Gupta S1
- Han Y1
- Argonne National Laboratory1
- Cardiff Catalysis Institute1
- Center for Nanophase Materials Sciences1
- Electron Microscope Center1
- Environmental Molecular Sciences Laboratory1
- Pacific Northwest National Laboratory1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials